EU drug watchdog to weigh in on extended use for remdesivir by summer

Click For Larger Image & Read More
EU drug watchdog to weigh in on extended use...
 © CyprusMail 2021
Europe’s drugs regulator said on Tuesday it was expecting to give an opinion before the summer on whether Gilead Sciences’ remdesivir can be used to treat COVID-19 patients who do not need oxygen support.

The indication for extended use, if approved, would allow the antiviral treatment to be given to more patients as coronavirus infections surge and healthcare systems are pressured by emerging, highly transmissible variants of the virus.

U.S.-based developer Gilead has submitted data to the European Medicines Agency (EMA), the watchdog said, adding that its human medicines committee...


Read all latest: Cyprus Coronavirus News Updates - Live

This article was automatically added to our system 1 week ago

EU drug watchdog to weigh in on extended use for remdesivir by summer


The contents of this article including any associated images are © CyprusMail 2021
Views & opinions expressed in this article are those of the author and/or CyprusMail .

Advertise Here

  Trending Cyprus News

Advertise Here

Article Tags: watchdog, weigh, extended, remdesivir, summer,